Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate Other stock markets 06:26:13 2026-08-07 am EDT			5-day change	1st Jan Change
59.00 ^EUR	+0.68%		+0.85%	-7.01%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.45B		BBB
ELI LILLY AND COMPANY	1,062B		A
JOHNSON & JOHNSON	619B	-	BBB	-	-
ABBVIE INC.	431B		AA	-
ROCHE HOLDING AG	358B		AA
NOVARTIS AG	293B		AAA
ASTRAZENECA PLC	247B		A
AMGEN INC.	219B		A
NOVO NORDISK A/S	200B		A
GILEAD SCIENCES, INC.	162B		AA
PFIZER INC.	149B		A
BRISTOL-MYERS SQUIBB COMPANY	131B		A
VERTEX PHARMACEUTICALS INCORPORATED	123B		AA
GSK PLC	104B		AA
SANOFI	103B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.25B		AA
BAYER AG	55.93B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	54.68B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	50.96B		AA
HALEON PLC	43.92B		AA
Average	224.08B		AA
Weighted average by Cap.			AA

×